Vivek Das, PhD, M.Sc.

Making Denmark a global frontrunner in brain research and innovation🧠 At BioInnovation Institute (BII), we’re proud to partner with the Lundbeckfonden / Lundbeck Foundation to accelerate innovation in brain health. The Lundbeck Foundation brings a deep knowledge base and a strong network within brain diseases. By combining that with BII's innovation platform and a thriving Danish innovation ecosystem with world-class universities and a highly regarded life science industry, we can position Denmark even more strongly on the global stage. As part of the partnership, BII and the Lundbeck Foundation will allocate over EUR 40M to develop groundbreaking treatments for brain diseases, and we expect to support 20-22 companies over 5.5 years. Thus, the partnership will be essential in attracting talent, knowledge, and investments to improve patient treatment. You can read more about the partnership here: https://bit.ly/4h17mzu Lene Skole Jan Egebjerg

522

11 Kommentarer

Professor receives DKK 10 million grant to improve cirrhosis treatment Professor Peter Jepsen from the Department of Clinical Medicine has secured a DKK 10 million grant from the Novo Nordisk Foundation to improve cirrhosis treatment through better collaboration between hospital and general practitioners (GPs). Currently, cirrhosis patients are treated almost exclusively in hospitals despite regular GP contact. Peter Jepsen's project "Shared care for patients with cirrhosis" will test new models to bring quality care closer to patients' homes through two pilot studies in Denmark and England. "We need to improve and change the treatment of cirrhosis - and to do that, we need to involve both patients and GPs in the process," says Peter Jepsen. The research will explore GP-led screening, preventive care, and digital communication via e-Boks to improve the collaboration between healthcare sectors. We look forward to seeing the results of the study. Learn more about the research by visiting the faculty website. 📷: Mimosa Foto.

243

34 Kommentarer

Today, we are thrilled to announce that Ionis’ and Sobi - Swedish Orphan Biovitrum AB (publ)’s treatment for familial chylomicronemia syndrome (FCS) has been approved in the European Union (EU). Read more about the news: https://lnkd.in/eKgqyYV9

692

14 Kommentarer

STATENS SERUM INSTITUT AWARDED GRANT TO ADVANCE AI-ASSISTED VACCINE RESEARCH We are proud to share that Tu Hu and the team at Statens Serum Institut (SSI) have been awarded a grant from the Novo Nordisk Foundation. The grant includes credits for GPU hours to harness Denmark’s most powerful supercomputer, Gefion, in the fight against infectious diseases. This project will use artificial intelligence to assist scientists in analyzing complex immune system data and identify patterns that are difficult to detect using traditional methods. This will help us understand how immune cells respond to infections like tuberculosis and influenza, and the team thus aims to accelerate the development of next-generation vaccines. By combining AI and supercomputing, researchers will be able to rapidly analyze large-scale immune data, leading to faster insights and more efficient vaccine development. This will strengthen Denmark’s position at the forefront of biomedical innovation and contribute to protecting both Danish society and global public health. SSI has entered into a strategic partnership with the NIVI Research Center (UCPH), which is an integral part of the Novo Nordisk Foundation Initiative for Vaccines and Immunity (NIVI). Through this partnership, SSI plays an important role in fostering cross-disciplinary collaboration between leading Danish research environments. This project represents an early step toward NIVI’s vision to unlock new possibilities in vaccine innovation and pave the way for future discoveries. #AI #Supercomputing #VaccineResearch #Immunology #BiomedicalInnovation #GlobalHealth

116

3 Kommentarer

🔬 Driving innovation in molecular diagnostics for ATMP With a decades-long track record in molecular analysis, Mikael Kubista—a Swedish researcher and entrepreneur—has founded Precision BioAnalytics, a new company based at GoCo Health Innovation City in Mölndal. The company develops more sensitive and reliable molecular diagnostics to support research, clinical diagnostics, and the development of cell and gene therapies. One area of particular promise is the earlier detection of infectious diseases like tuberculosis, where more accessible and precise diagnostics could have global impact. 🧪 Precision BioAnalytics is strategically connected to the Swedish ATMP innovation cluster through collaborations with Göteborgs universitet , Sahlgrenska Universitetssjukhuset, Chalmers tekniska högskola, AstraZeneca, and CCRM Nordic, which supports the field with infrastructure for clinical-grade manufacturing. The team’s ambition is to strengthen Sweden’s position in molecular diagnostics—an essential component in enabling safe and effective advanced therapies. 🔗 Read more: https://lnkd.in/dPxKWK32 #ATMP #MolecularDiagnostics #GeneTherapy #CellTherapy #LifeScienceSweden #GoCoHealthInnovationCity #PrecisionBioAnalytics #CCRMNordic #ATMP2030 #SwedishInnovation

61

3 Kommentarer

Pandemics will come around again. Managing a pandemic with minimal losses is all about being well-prepared. The Novo Nordisk Foundation is now contributing to pandemic preparedness with a new infrastructure, the Global Pathogen Analysis Platform (GPAP) — an AI-driven infrastructure that will make advanced pathogen analysis freely available to researchers and health authorities everywhere.   The GPAP platform will integrate genomics, clinical, and environmental data and will be developed in collaboration with partners across continents. A couple of features make GPAP unique: its one-Health approach, its co-creation with partners in LMIC countries, and its independence of commercial interests. GPAP's central hub will be at DTU - Technical University of Denmark – with partner nodes at Københavns Universitet - University of Copenhagen, Statens Serum Institut and Imperial College London, and it will be lead by Professor Henrik Caspar Wegener   Read more about the initiative here: https://lnkd.in/d6X9F4CK

144

5 Kommentarer

16 researchers from DTU have received an Experiment grant from the Villum Foundation to realise their innovative research ideas. 𝗛𝗲𝗿𝗲 𝗮𝗿𝗲 𝘁𝗵𝗲 𝟭𝟲 𝗴𝗿𝗮𝗻𝘁 𝗿𝗲𝗰𝗶𝗽𝗶𝗲𝗻𝘁𝘀 👇 • Professor Brian Seger, DTU Physics, receives the grant for the project ’CO2 electrolysis to pharmaceuticals’. • Postdoc Colleen Manyumwa, PhD, DTU Biosustain, receives the grant for the project ‘PlastiXterminator: Next-Gen Synergistic Enzyme Complexes for Microplastic Degradation’. • Postdoc Emil Hovad, DTU Compute, receives the grant for the project ‘Scientific machine learning for advancing the understanding of the 4D microstructural evolution in metals (SciML4D)’. • Researcher Gaoneng Dong, DTU Electro, receives the grant for the project ‘Unlocking silicon's hidden power: on-chip phase transitions enabled by a new nanocavity’. • Postdoc Innokentiy Zhdanov, DTU Electro, receives the grant for the project ‘Room temperature integrated light-squeezing single-photon detectors for quantum systems’. • Professor Jakob Birkedal Wagner, DTU Nanolab, receives the grant for the project ‘Sub-Ångström 3D Mapping of Single Impurities in Crystals via Scanning Transmission Electron Microscopy’. • Researcher Nefeli Novak, DTU Chemical and Biochemical Engineering, receives the grant for the project ‘Can the two-state theory of water revolutionize aqueous solutions?’. • Senior Researcher Nikolas Angelou, DTU Wind and Energy Systems, receives the grant for the project ‘Laser-based unmanned aircraft system for wind sensing’. • Postdoc Riccardo Ragona, DTU Physics, receives the grant for the project ‘PAMS; Looking at fusion plasmas with new eyes’. • Senior Researcher Shima Kadkhodazadeh, DTU Nanolab, receives the grant for the project ‘Live Band Nanoscopy: Mapping electronic bands in working photoelectrochemical devices’. • Professor Wei Yan, DTU Chemistry, receives the grant for the project ’Tackling the Forever Problem: Thermodynamic Solutions to PFAS Pollution’. • Researcher Weihua Tian, DTU Bioengineering, receives the grant for the project ‘Engineering an extracellular vesicles-based transfection method for challenging-to-transfect cells’. • Professor Wenjing (Angela) ZHANG, DTU Sustain, receives the grant for the project ‘PlasUp: Rekindle Plastic Waste Upcycling by Microwave Reactor with High-Entropy Catalyst’. • Postdoc Xavier Zambrana-Puyalto, DTU Physics, receives the grant for the project ‘Van der Waals meta-crystal for valleytronics’. • Researcher Yong Liu, DTU Electro, receives the grant for the project ‘Watt-class Optical Beam Steering on Silicon Photonics’. • Postdoc Zhenghao Liu, DTU Physics, receives the grant for the project ‘Feedforward-enabled synthetic dimension photonics’. Congratulations 🎉🦾 #DTUdk #TechnologyForPeople #Engineering #Sustainability #Innovation #DigitalTransformation #Diversity

290

1 Kommentar

New evidence shows that women with #PCOS face elevated risks of #autoimmune #disease not only after diagnosis, but years before. A study in Clinical Endocrinology by Dorte Glintborg, Marianne Skovsager Andersen, and colleagues followed more than 30,000 women with PCOS and 150,000 matched controls across the Danish national health registries. The findings are notable: • Women with PCOS were about 50 percent more likely to develop an autoimmune disease compared to controls • This elevated risk was evident years before diagnosis and persisted afterward • The strongest signals were for type 1 diabetes, where women with PCOS were more than three times as likely to be affected after diagnosis, and for autoimmune thyroid disease • Risk was higher among women with PCOS who also had higher BMI, infertility, comorbidities, or lower income 💡 Why this matters These results show that women with PCOS are more likely to develop autoimmune disease than women without PCOS. Importantly, the excess risk was already present long before a formal PCOS diagnosis, suggesting shared biology rather than treatment effects or increased medical surveillance alone. Limitations and next steps The study relies on registry data, so it cannot capture antibody status, disease activity, or detailed PCOS phenotypes. Still, the consistency of elevated risk across both pre- and post-diagnosis windows argues for meaningful links between endocrine, metabolic, and immune pathways. Future research should integrate biomarkers, phenotyping, and longitudinal follow-up to clarify mechanisms and test whether improving metabolic health can reduce autoimmune risk. This work adds to the growing recognition that women’s health research must embrace the intersections of reproductive, metabolic, and immune pathways. At GSD Health Research, we are focused on ensuring studies and trials capture these intersections to better reflect the full picture of women’s health. Congratulations to the authors for advancing our understanding of the links between PCOS and autoimmunity. #WomensHealth #AutoimmuneDisease #PCOS #ClinicalResearch #MedicalResearch #SexDifferences

69

2 Kommentarer